Zebrafish model of tuberous sclerosis complex reveals cell-autonomous and non-cell-autonomous functions of mutant tuberin

SUMMARY Tuberous sclerosis complex (TSC) is an autosomal dominant disease caused by mutations in either the TSC1 (encodes hamartin) or TSC2 (encodes tuberin) genes. Patients with TSC have hamartomas in various organs throughout the whole body, most notably in the brain, skin, eye, heart, kidney and lung. To study the development of hamartomas, we generated a zebrafish model of TSC featuring a nonsense mutation (vu242) in the tsc2 gene. This tsc2vu242 allele encodes a truncated Tuberin protein lacking the GAP domain, which is required for inhibition of Rheb and of the TOR kinase within TORC1. We show that tsc2vu242 is a recessive larval-lethal mutation that causes increased cell size in the brain and liver. Greatly elevated TORC1 signaling is observed in tsc2vu242/vu242 homozygous zebrafish, and is moderately increased in tsc2vu242/+ heterozygotes. Forebrain neurons are poorly organized in tsc2vu242/vu242 homozygous mutants, which have extensive gray and white matter disorganization and ectopically positioned cells. Genetic mosaic analyses demonstrate that tsc2 limits TORC1 signaling in a cell-autonomous manner. However, in chimeric animals, tsc2vu242/vu242 mutant cells also mislocalize wild-type host cells in the forebrain in a non-cell-autonomous manner. These results demonstrate a highly conserved role of tsc2 in zebrafish and establish a new animal model for studies of TSC. The finding of a non-cell-autonomous function of mutant cells might help explain the formation of brain hamartomas and cortical malformations in human TSC.

[1]  Alcino J. Silva,et al.  Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis , 2008, Nature Medicine.

[2]  V. Poukens,et al.  Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study , 1997, Acta Neuropathologica.

[3]  J. Wheless,et al.  Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States , 2007, Genetics in Medicine.

[4]  S. Fraser,et al.  Order and coherence in the fate map of the zebrafish nervous system. , 1995, Development.

[5]  K. Inoki,et al.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.

[6]  H. Onda,et al.  Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/− cells , 2002, Oncogene.

[7]  B. Scheithauer,et al.  Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. , 1996, American journal of human genetics.

[8]  S. Prabhakar,et al.  Bacterial meningitis and epilepsy , 2008, Epilepsia.

[9]  L. Lettice,et al.  Whole-mount in situ hybridizations on zebrafish embryos using a mixture of digoxigenin- and fluorescein-labelled probes. , 1994, Trends in genetics : TIG.

[10]  M. Wong.  Mechanisms of Epileptogenesis in Tuberous Sclerosis Complex and Related Malformations of Cortical Development with Abnormal Glioneuronal Proliferation , 2008, Epilepsia.

[11]  B. Manning,et al.  The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. , 2008, The Biochemical journal.

[12]  S. Pauls,et al.  - Ortega A zebrafish histone variant H 2 A . F / Z and a transgenic H 2 A . F / Z : GFP fusion protein for in vivo studies of embryonic development , 2022 .

[13]  Wei Zhang,et al.  Pharmacological Inhibition of mTORC1 Suppresses Anatomical, Cellular, and Behavioral Abnormalities in Neural-Specific Pten Knock-Out Mice , 2009, The Journal of Neuroscience.

[14]  F. Elmslie,et al.  Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis. , 2008, The New England journal of medicine.

[15]  M. Wullimann,et al.  An Evolutionary Interpretation of Teleostean Forebrain Anatomy , 2009, Brain, Behavior and Evolution.

[16]  B. Scheithauer.  The Neuropathology of Tuberous Sclerosis , 1992, The Journal of dermatology.

[17]  D. Kwiatkowski,et al.  A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes. , 2005, Human molecular genetics.

[18]  E. Aronica,et al.  Biallelic TSC gene inactivation in tuberous sclerosis complex , 2010, Neurology.

[19]  G. Thomas,et al.  The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb. , 2004, Novartis Foundation symposium.

[20]  Wael Tadros,et al.  The maternal-to-zygotic transition: a play in two acts , 2009, Development.

[21]  S. Baraban,et al.  A Large‐scale Mutagenesis Screen to Identify Seizure‐resistant Zebrafish , 2007, Epilepsia.

[22]  G. Sethuraman,et al.  Rapamycin causes regression of astrocytomas in tuberous sclerosis complex , 2006, Annals of neurology.

[23]  F. Jensen,et al.  Cell‐specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers , 2008, Annals of neurology.

[24]  H. Onda,et al.  Astrocyte‐specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures , 2002, Annals of neurology.

[25]  P. Crino.  Molecular Pathogenesis of Tuber Formation in Tuberous Sclerosis Complex , 2004, Journal of child neurology.

[26]  R. Stoyanova,et al.  Tsc1+ and tsc2+ Regulate Arginine Uptake and Metabolism in Schizosaccharomyces pombe* , 2004, Journal of Biological Chemistry.

[27]  Zhaoxia Sun,et al.  Zebrafish Tsc1 reveals functional interactions between the cilium and the TOR pathway. , 2009, Human molecular genetics.

[28]  L. Romão,et al.  The mammalian nonsense‐mediated mRNA decay pathway: To decay or not to decay! Which players make the decision? , 2009, FEBS letters.

[29]  K. Ess.  The neurobiology of tuberous sclerosis complex. , 2006, Seminars in pediatric neurology.

[30]  C. Nüsslein-Volhard,et al.  Large-scale mutagenesis in the zebrafish: in search of genes controlling development in a vertebrate , 1994, Current Biology.

[31]  Vincent J Schmithorst,et al.  Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. , 2008, The New England journal of medicine.

[32]  B. Manning,et al.  A complex interplay between Akt, TSC2 and the two mTOR complexes. , 2009, Biochemical Society transactions.

[33]  D. Gutmann,et al.  Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex , 2008, Annals of neurology.

[34]  T. Noda,et al.  Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice. , 1999, Cancer research.

[35]  Steven Henikoff,et al.  Large-scale discovery of induced point mutations with high-throughput TILLING. , 2003, Genome research.

[36]  A. Ouweland,et al.  Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype – phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex , 2005, European Journal of Human Genetics.

[37]  Alan N. Mayer,et al.  Target of rapamycin (TOR) signaling controls epithelial morphogenesis in the vertebrate intestine. , 2007, Developmental biology.

[38]  Mustafa Sahin,et al.  Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function , 2008, The Journal of Neuroscience.

[39]  Chi‐Kuang Sun,et al.  Biomolecular imaging based on far-red fluorescent protein with a high two-photon excitation action cross section. , 2006, Optics letters.

[40]  V. Korzh,et al.  In vivo Analysis of Choroid Plexus Morphogenesis in Zebrafish , 2008, PloS one.

[41]  Tetsuo Noda,et al.  A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[42]  H. Onda,et al.  Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. , 1999, The Journal of clinical investigation.

[43]  A. Schier,et al.  Efficient recovery of ENU-induced mutations from the zebrafish germline. , 1994, Genetics.

[44]  M. S. Cooper,et al.  Visualizing morphogenesis in transgenic zebrafish embryos using BODIPY TR methyl ester dye as a vital counterstain for GFP , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[45]  K. Inoki,et al.  Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. , 2003, Genes & development.

[46]  J. Campos-Ortega,et al.  A zebrafish histone variant H2A.F/Z and a transgenic H2A.F/Z:GFP fusion protein for in vivo studies of embryonic development , 2001, Development Genes and Evolution.

[47]  O. Houser,et al.  MR findings in tuberous sclerosis complex and correlation with seizure development and mental impairment. , 1995, AJNR. American journal of neuroradiology.

[48]  Y. Kubo,et al.  A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer , 1995, Nature Genetics.

[49]  Paul Tempst,et al.  Phosphorylation and Functional Inactivation of TSC2 by Erk Implications for Tuberous Sclerosisand Cancer Pathogenesis , 2005, Cell.

[50]  M. Gambello,et al.  Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse , 2009, Human molecular genetics.

[51]  B. Taillon,et al.  Analysis of TSC Cortical Tubers by Deep Sequencing of TSC1, TSC2 and KRAS Demonstrates that Small Second‐Hit Mutations in these Genes are Rare Events , 2010, Brain pathology.

[52]  P. Schwartzkroin,et al.  Irradiation exacerbates cortical cytopathology in the Eker rat model of tuberous sclerosis complex, but does not induce hyperexcitability , 2007, Epilepsy Research.

[53]  D. Brat,et al.  Transgenic Expression of Dominant Negative Tuberin through a Strong Constitutive Promoter Results in a Tissue-specific Tuberous Sclerosis Phenotype in the Skin and Brain* , 2005, Journal of Biological Chemistry.

[54]  P. Crino,et al.  Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model , 2003, Annals of neurology.

[55]  B. Edgar,et al.  Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins , 2003, Nature Cell Biology.